220 related articles for article (PubMed ID: 24553576)
1. Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.
Varani AP; Aso E; Moutinho LM; Maldonado R; Balerio GN
Psychopharmacology (Berl); 2014 Aug; 231(15):3031-40. PubMed ID: 24553576
[TBL] [Abstract][Full Text] [Related]
2. Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice.
Pedrón VT; Varani AP; Balerio GN
Synapse; 2016 May; 70(5):187-97. PubMed ID: 26789010
[TBL] [Abstract][Full Text] [Related]
3. Nicotine-induced molecular alterations are modulated by GABA
Varani AP; Pedrón VT; Aon AJ; Höcht C; Acosta GB; Bettler B; Balerio GN
Addict Biol; 2018 Jan; 23(1):230-246. PubMed ID: 28419642
[TBL] [Abstract][Full Text] [Related]
4. Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice.
Bagdas D; Muldoon PP; Zhu AZ; Tyndale RF; Damaj MI
Neuropharmacology; 2014 Oct; 85():67-72. PubMed ID: 24859605
[TBL] [Abstract][Full Text] [Related]
5. Both nicotine reward and withdrawal are enhanced in a rodent model of diabetes.
Pipkin JA; Cruz B; Flores RJ; Hinojosa CA; Carcoba LM; Ibarra M; Francis W; Nazarian A; O'Dell LE
Psychopharmacology (Berl); 2017 May; 234(9-10):1615-1622. PubMed ID: 28342091
[TBL] [Abstract][Full Text] [Related]
6. Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats.
Yamada H; Bishnoi M; Keijzers KF; van Tuijl IA; Small E; Shah HP; Bauzo RM; Kobeissy FH; Sabarinath SN; Derendorf H; Bruijnzeel AW
Pharmacol Biochem Behav; 2010 Jun; 95(4):401-9. PubMed ID: 20211642
[TBL] [Abstract][Full Text] [Related]
7. GABA(B) receptors involvement in the effects induced by nicotine on anxiety-related behaviour in mice.
Varani AP; Balerio GN
Pharmacol Res; 2012 May; 65(5):507-13. PubMed ID: 22430317
[TBL] [Abstract][Full Text] [Related]
8. In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
Jackson A; Bagdas D; Muldoon PP; Lichtman AH; Carroll FI; Greenwald M; Miles MF; Damaj MI
Neuropharmacology; 2017 May; 118():38-45. PubMed ID: 28279662
[TBL] [Abstract][Full Text] [Related]
9. Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in mice.
Jackson KJ; Jackson A; Carroll FI; Damaj MI
Neuropharmacology; 2015 Oct; 97():270-4. PubMed ID: 26044637
[TBL] [Abstract][Full Text] [Related]
10. Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice.
Buzzi B; AlSharari SD; Walentiny DM; Damaj MI
Behav Brain Res; 2024 Jun; 467():115019. PubMed ID: 38677331
[TBL] [Abstract][Full Text] [Related]
11. Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal.
Varani AP; Moutinho LM; Calvo M; Balerio GN
Drug Alcohol Depend; 2011 Dec; 119(1-2):e5-12. PubMed ID: 21733642
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine decreased nicotine reward-like properties and withdrawal in mice.
Bowers MS; Jackson A; Maldoon PP; Damaj MI
Psychopharmacology (Berl); 2016 Mar; 233(6):995-1003. PubMed ID: 26676982
[TBL] [Abstract][Full Text] [Related]
13. The endogenous cannabinoid system modulates nicotine reward and dependence.
Merritt LL; Martin BR; Walters C; Lichtman AH; Damaj MI
J Pharmacol Exp Ther; 2008 Aug; 326(2):483-92. PubMed ID: 18451315
[TBL] [Abstract][Full Text] [Related]
14. The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat.
Paterson NE; Semenova S; Markou A
Psychopharmacology (Berl); 2008 Jun; 198(3):351-62. PubMed ID: 18438738
[TBL] [Abstract][Full Text] [Related]
15. Anxiety status affects nicotine- and baclofen-induced locomotor activity, anxiety, and single-trial conditioned place preference in male adolescent rats.
Falco AM; McDonald CG; Smith RF
Dev Psychobiol; 2014 Sep; 56(6):1352-64. PubMed ID: 24719177
[TBL] [Abstract][Full Text] [Related]
16. Baclofen and 2-hydroxysaclofen modify acute hypolocomotive and antinociceptive effects of nicotine.
Varani AP; Aso E; Maldonado R; Balerio GN
Eur J Pharmacol; 2014 Sep; 738():200-5. PubMed ID: 24886886
[TBL] [Abstract][Full Text] [Related]
17. The role of CA3 GABA
Zarrabian S; Nasehi M; Farrahizadeh M; Zarrindast MR
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):515-524. PubMed ID: 28800869
[TBL] [Abstract][Full Text] [Related]
18. Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats.
Vlachou S; Paterson NE; Guery S; Kaupmann K; Froestl W; Banerjee D; Finn MG; Markou A
Eur J Pharmacol; 2011 Mar; 655(1-3):52-8. PubMed ID: 21262222
[TBL] [Abstract][Full Text] [Related]
19. The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal.
Jackson KJ; McIntosh JM; Brunzell DH; Sanjakdar SS; Damaj MI
J Pharmacol Exp Ther; 2009 Nov; 331(2):547-54. PubMed ID: 19644040
[TBL] [Abstract][Full Text] [Related]
20. Lack of GABAB receptors modifies behavioural and biochemical alterations induced by precipitated nicotine withdrawal.
Varani AP; Pedrón VT; Machado LM; Antonelli MC; Bettler B; Balerio GN
Neuropharmacology; 2015 Mar; 90():90-101. PubMed ID: 25479464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
